| Phage display as a technology delivering on the promise of peptide drug discovery M Hamzeh-Mivehroud, AA Alizadeh, MB Morris, WB Church, ... Drug discovery today 18 (23-24), 1144-1157, 2013 | 204 | 2013 |
| Histamine H3 receptor antagonists/inverse agonists: Where do they go? N Ghamari, O Zarei, JA Arias-Montaño, D Reiner, S Dastmalchi, H Stark, ... Pharmacology & Therapeutics 200, 69-84, 2019 | 69 | 2019 |
| A simple and rapid protocol for producing yeast extract from Saccharomyces cerevisiae suitable for preparing bacterial culture media O Zarei, S Dastmalchi, M Hamzeh-Mivehroud Iranian journal of pharmaceutical research: IJPR 15 (4), 907, 2016 | 63 | 2016 |
| Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s … G Ghotbi, M Mahdavi, Z Najafi, FH Moghadam, M Hamzeh-Mivehroud, ... Bioorganic Chemistry 103, 104186, 2020 | 52 | 2020 |
| Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain A Safary, R Moniri, M Hamzeh-Mivehroud, S Dastmalchi BioImpacts: BI 9 (1), 15, 2019 | 46 | 2019 |
| Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists S Dastmalchi, M Hamzeh-Mivehroud, T Ghafourian, H Hamzeiy Journal of Molecular Graphics and Modelling 26 (5), 834-844, 2008 | 46 | 2008 |
| Identification of new peptide ligands for epidermal growth factor receptor using phage display and computationally modeling their mode of binding M Hamzeh‐Mivehroud, A Mahmoudpour, S Dastmalchi Chemical biology & drug design 79 (3), 246-259, 2012 | 40 | 2012 |
| Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier M Hamzeh-Mivehroud, A Mahmoudpour, H Rezazadeh, S Dastmalchi European Journal of Pharmaceutics and Biopharmaceutics 70 (2), 577-581, 2008 | 37 | 2008 |
| Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects N Ghamari, O Zarei, D Reiner, S Dastmalchi, H Stark, ... Chemical Biology & Drug Design 93 (5), 832-843, 2019 | 32 | 2019 |
| Structure-based investigation of rat aldehyde oxidase inhibition by flavonoids M Hamzeh-Mivehroud, S Rahmani, MR Rashidi, MA Hosseinpour Feizi, ... Xenobiotica 43 (8), 661-670, 2013 | 32 | 2013 |
| Optimization of UV irradiation mutation conditions for cellulase production by mutant fungal strains of Aspergillus niger through solid state fermentation N Jafari, H Jafarizadeh-Malmiri, M Hamzeh-Mivehroud, M Adibpour Green Processing and Synthesis 6 (3), 333-340, 2017 | 31 | 2017 |
| Design, synthesis, and biological evaluation of novel benzo [b] thiophene-diaryl urea derivatives as potential anticancer agents O Zarei, F Azimian, M Hamzeh-Mivehroud, J Shahbazi Mojarrad, ... Medicinal Chemistry Research 29, 1438-1448, 2020 | 29 | 2020 |
| A strategy for soluble overexpression and biochemical characterization of halo-thermotolerant Bacillus laccase in modified E. coli A Safary, R Moniri, M Hamzeh-Mivehroud, S Dastmalchi Journal of Biotechnology 227, 56-63, 2016 | 25 | 2016 |
| Methods and algorithms for molecular docking-based drug design and discovery S Dastmalchi IGI Global, 2016 | 25 | 2016 |
| Synthesis of 2‐pyrazolines from hydrazines: Mechanisms explained T Vahedpour, M Hamzeh‐Mivehroud, S Hemmati, S Dastmalchi ChemistrySelect 6 (25), 6483-6506, 2021 | 24 | 2021 |
| Current trends in development of HDAC-based chemotherapeutics N Cheshmazar, M Hamzeh-Mivehroud, HN Charoudeh, S Hemmati, ... Life Sciences 308, 120946, 2022 | 23 | 2022 |
| Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach F Azimian, M Hamzeh-Mivehroud, JS Mojarrad, S Hemmati, S Dastmalchi European Journal of Medicinal Chemistry 201, 112461, 2020 | 23 | 2020 |
| Comparison of different 2D and 3D-QSAR methods on activity prediction of histamine H3 receptor antagonists S Dastmalchi, M Hamzeh-Mivehroud, K Asadpour-Zeynali Iranian journal of pharmaceutical research: IJPR 11 (1), 97, 2012 | 21 | 2012 |
| Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery O Zarei, S Benvenuti, F Ustun-Alkan, M Hamzeh-Mivehroud, S Dastmalchi Journal of cancer research and clinical oncology 142, 2429-2446, 2016 | 20 | 2016 |
| In Vitro and In Silico Studies to Explore Structural Features of Flavonoids for Aldehyde Oxidase Inhibition M Hamzeh‐Mivehroud, S Rahmani, MAH Feizi, S Dastmalchi, MR Rashidi Archiv der Pharmazie 347 (10), 738-747, 2014 | 20 | 2014 |
A. Ghasem JouybanProfessor of Pharmaceutical Analysis, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
